berberine has been researched along with imatinib mesylate in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 5 (100.00) | 2.80 |
Authors | Studies |
---|---|
Fei, J; Gu, C; Huang, G; Liu, Y; Yang, J; Yin, Z | 1 |
Elf, SE | 1 |
Adiwidjaja, J; Boddy, AV; McLachlan, AJ | 1 |
Li, D; Song, C; Zhang, J; Zhao, X | 1 |
Fei, J; Hu, H; Huang, G; Li, C; Liu, Y; Nie, H; Su, R; Wang, X; Wen, Z; Yang, J; Yin, Z; Zeng, X | 1 |
5 other study(ies) available for berberine and imatinib mesylate
Article | Year |
---|---|
Discovery of Berberine that Targetedly Induces Autophagic Degradation of both BCR-ABL and BCR-ABL T315I through Recruiting LRSAM1 for Overcoming Imatinib Resistance.
Topics: Animals; Apoptosis; Berberine; Berberis; Cell Proliferation; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Mice; Molecular Docking Simulation; Proto-Oncogene Proteins c-bcr; Signal Transduction; Trees; Ubiquitin-Protein Ligases | 2020 |
"All Our Wisdom is Stored in the Trees" - Degrading BCR-ABL with
Topics: Antineoplastic Agents; Benzamides; Berberine; Berberis; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Piperazines; Pyrimidines; Trees; Ubiquitin-Protein Ligases | 2020 |
Physiologically based pharmacokinetic model predictions of natural product-drug interactions between goldenseal, berberine, imatinib and bosutinib.
Topics: Aniline Compounds; Berberine; Biological Products; Cytochrome P-450 CYP3A; Drug Interactions; Humans; Hydrastis; Imatinib Mesylate; Models, Biological; Nitriles; Quinolines | 2022 |
Berberine hydrochloride alleviates imatinib mesylate - induced cardiotoxicity through the inhibition of Nrf2-dependent ferroptosis.
Topics: Animals; Berberine; Biomarkers; Cardiotoxicity; Ferroptosis; Imatinib Mesylate; Iron; Mice; NF-E2-Related Factor 2; Rats; Reactive Oxygen Species | 2023 |
System analysis of Huang-Lian-Jie-Du-Tang and their key active ingredients for overcoming CML resistance by suppression of leukemia stem cells.
Topics: Animals; Berberine; Drug Resistance, Neoplasm; Fusion Proteins, bcr-abl; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Mice; Myeloid Cell Leukemia Sequence 1 Protein; Protein Kinase Inhibitors; Stem Cells | 2023 |